Tag: DIOV
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
No reduction seen in the composite outcome of cardiovascular mortality, hospitalization due to heart failure
Shared, Sex-Specific Body Fat Patterns Linked to Cardiovascular Aging
In both sexes, visceral adipose tissue volume, muscle adipose tissue infiltration, liver fat fraction were strongest predictors of CV age
Intensive Systolic BP Target Cost-Effective for Patients at High Cardiovascular Risk
Intensive target <120 mm Hg cost-effective even in scenarios with high measurement error
COVID-19 Infection Linked to Accelerated Vascular Aging
In study, all COVID-19-positive groups showed higher carotid-femoral pulse wave velocity, especially women
Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors
Overall, 68.9 percent of participants who underwent screening at health stations had uncontrolled cardiovascular risk factors
‘Heart Age’ Often Older Than Chronological Age
Discordance was greater for middle-aged adults, racial and ethnic minorities, and for those with lower educational attainment
FDA Warns About Safety Issues With Boston Scientific Heart Devices
CPAP Preferentially Improves Cardiovascular Outcomes in High-Risk OSA
Stronger differential effect for CPAP seen for those without excessive sleepiness, without increased blood pressure
CVD Mortality Varies Among Asian Indian, Chinese, Filipino Americans
Filipino Americans have the highest mortality across most cardiovascular conditions
Physical Activity Steadily Declines From Young Adulthood to Middle Age
MVPA begins declining about 12 years before cardiovascular disease, with accelerated declines within two years of event
